|
DYNC1I2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.798600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.711600E-01 |
| Normal-vs-Stage2 |
3.351900E-02 |
| Normal-vs-Stage3 |
4.252000E-01 |
| Normal-vs-Stage4 |
8.266800E-01 |
| Stage1-vs-Stage2 |
1.055940E-02 |
| Stage1-vs-Stage3 |
2.200800E-01 |
| Stage1-vs-Stage4 |
6.534200E-01 |
| Stage2-vs-Stage3 |
1.291210E-01 |
| Stage2-vs-Stage4 |
8.080400E-02 |
| Stage3-vs-Stage4 |
6.521400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.903600E-01 |
| Normal-vs-AfricanAmerican |
4.274200E-01 |
| Normal-vs-Asian |
4.746800E-01 |
| Caucasian-vs-AfricanAmerican |
3.347800E-01 |
| Caucasian-vs-Asian |
3.523800E-01 |
| AfricanAmerican-vs-Asian |
8.331400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.643000E-01 |
| Normal-vs-Female |
9.450000E-01 |
| Male-vs-Female |
1.909210E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.276600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.578200E-01 |
| Normal-vs-Age(61-80Yrs) |
5.404100E-02 |
| Normal-vs-Age(81-100Yrs) |
3.521000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.804000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.379300E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.153400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.318750E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.459600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.091600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.545200E-01 |
| Classical-VS-Follicular |
2.51709997289851E-09 |
| Classical-VS-Other |
3.183600E-01 |
| Classical-VS-Normal |
2.744600E-01 |
| Tall-VS-Follicular |
3.61079999999792E-05 |
| Tall-VS-Other |
2.020800E-01 |
| Tall-VS-Normal |
1.468240E-01 |
| Follicular-VS-Other |
3.486200E-01 |
| Follicular-VS-Normal |
3.799000E-04 |
| Other-VS-Normal |
6.319200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.733700E-02 |
| Normal-vs-N1 |
8.632400E-01 |
| N0-vs-N1 |
1.851370E-01 |
|
|
